Sundar Kodiyalam Fund I net IRR of 58.4% Harvard Medical School Lewis Cantley Capital- efficiency Substantial Exit History Oncology Corporate Spinouts Strategic Partnerships San Diego Office Gene Yeo, Ph.D. Syndication Partners New York Office Syndication WRF Capital $12.3 Million NIDA Grant 2014 Top- quartile Ranked Petra Pharma Rodeo Therapeutics Divestitures MD Anderson Cancer Center Entrepreneurs UT Southwestern Advisory & Corporate Boards Jan Lundberg, Ph.D. Top-tier Investors Leroy Hood, M.D., Ph.D. 150+ Years’ Experience The Rockefeller University Non- Dilutive Funding Dana Farber Cancer Gates Foundation Eli Lilly Academic & Research Institutions Lodo Therapeutics ARCH Venture Partners UT Southwestern Medical Center Operating Partners? $3.375 Billion Exit Neuroscience & Neurology Tachi Yamada, M.D. Apogen Biotechnologies Targeted Therapeutic (Asset) Financing Lodo Therapeutics (BARDA) – on updated slide deck Exceptional Track Record Weill Cornell Medicine Lydian Neurosciences Steve Gillis, Ph.D. 2.85 DVPI Columbia University Pfizer Ventures Singapore Office high-quality, cutting edge life science companies Employees Infectious Disease, Oncology, Microbiome Reviewed > 4,000 Opportunities Proniras Case Western Reserve Uniformed Services University WuXi PharmaTech University of Minnesota 1.02 DPI Weill Cornell Medicine Temasek Scientists & Technology Developers Turn- Key Facilities Magnolia Neurosciences Rodeo Therapeutics Alexandria Venture Investments 58.43% IRR AI & Machine Learning Seattle Office Venture Capital $1 Billion Genentech Collaboration CPRIT Diversity CSAB Members? Bruce L.A. Carter, Ph.D. Scientific Expertise Abbvie Gates Foundation The Rockefeller University Penn State Sundar Kodiyalam Fund I net IRR of 58.4% Harvard Medical School Lewis Cantley Capital- efficiency Substantial Exit History Oncology Corporate Spinouts Strategic Partnerships San Diego Office Gene Yeo, Ph.D. Syndication Partners New York Office Syndication WRF Capital $12.3 Million NIDA Grant 2014 Top- quartile Ranked Petra Pharma Rodeo Therapeutics Divestitures MD Anderson Cancer Center Entrepreneurs UT Southwestern Advisory & Corporate Boards Jan Lundberg, Ph.D. Top-tier Investors Leroy Hood, M.D., Ph.D. 150+ Years’ Experience The Rockefeller University Non- Dilutive Funding Dana Farber Cancer Gates Foundation Eli Lilly Academic & Research Institutions Lodo Therapeutics ARCH Venture Partners UT Southwestern Medical Center Operating Partners? $3.375 Billion Exit Neuroscience & Neurology Tachi Yamada, M.D. Apogen Biotechnologies Targeted Therapeutic (Asset) Financing Lodo Therapeutics (BARDA) – on updated slide deck Exceptional Track Record Weill Cornell Medicine Lydian Neurosciences Steve Gillis, Ph.D. 2.85 DVPI Columbia University Pfizer Ventures Singapore Office high-quality, cutting edge life science companies Employees Infectious Disease, Oncology, Microbiome Reviewed > 4,000 Opportunities Proniras Case Western Reserve Uniformed Services University WuXi PharmaTech University of Minnesota 1.02 DPI Weill Cornell Medicine Temasek Scientists & Technology Developers Turn- Key Facilities Magnolia Neurosciences Rodeo Therapeutics Alexandria Venture Investments 58.43% IRR AI & Machine Learning Seattle Office Venture Capital $1 Billion Genentech Collaboration CPRIT Diversity CSAB Members? Bruce L.A. Carter, Ph.D. Scientific Expertise Abbvie Gates Foundation The Rockefeller University Penn State
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Sundar Kodiyalam
Fund I net IRR of 58.4%
Harvard Medical School
Lewis Cantley
Capital-efficiency
Substantial Exit History
Oncology
Corporate Spinouts
Strategic Partnerships
San Diego Office
Gene Yeo, Ph.D.
Syndication Partners
New York Office
Syndication
WRF Capital
$12.3 Million NIDA Grant
2014 Top-quartile Ranked
Petra Pharma
Rodeo Therapeutics
Divestitures
MD Anderson Cancer Center
Entrepreneurs
UT Southwestern
Advisory & Corporate Boards
Jan Lundberg, Ph.D.
Top-tier Investors
Leroy Hood, M.D., Ph.D.
150+ Years’ Experience
The Rockefeller University
Non-Dilutive Funding
Dana Farber Cancer
Gates Foundation
Eli Lilly
Academic & Research Institutions
Lodo Therapeutics
ARCH Venture Partners
UT Southwestern Medical Center
Operating Partners?
$3.375 Billion Exit
Neuroscience & Neurology
Tachi Yamada, M.D.
Apogen Biotechnologies
Targeted Therapeutic (Asset) Financing
Lodo Therapeutics
(BARDA) – on updated slide deck
Exceptional Track Record
Weill Cornell Medicine
Lydian Neurosciences
Steve Gillis, Ph.D.
2.85 DVPI
Columbia University
Pfizer Ventures
Singapore Office
high-quality, cutting edge life science companies
Employees
Infectious Disease, Oncology, Microbiome
Reviewed > 4,000 Opportunities
Proniras
Case Western Reserve
Uniformed Services University
WuXi PharmaTech
University of Minnesota
1.02 DPI
Weill Cornell Medicine
Temasek
Scientists & Technology Developers
Turn-Key Facilities
Magnolia Neurosciences
Rodeo Therapeutics
Alexandria Venture Investments
58.43% IRR
AI & Machine Learning
Seattle Office
Venture Capital
$1 Billion Genentech Collaboration
CPRIT
Diversity
CSAB Members?
Bruce L.A. Carter, Ph.D.
Scientific Expertise
Abbvie
Gates Foundation
The Rockefeller University
Penn State